Location Tampa, Florida, United States Regions Tampa Bay Area, East Coast, Southern US Gender Male
LinkedIn View on LinkedIn
With 30 years Global Life Science experience including 18 years in Ophthalmology, Michael has managed 26 brands, led 13 product launches, structured multiple strategic business deals and has been a team member in 19 device/drug approvals.
He was previously General Manager for the Bausch + Lomb U.S. Pharmaceuticals division, leading it to
significant growth, and held senior global strategy positions in Pharmaceutical, Drug Delivery and Surgical. His extensive drug delivery experience includes the commercial launch of the world’s first intra ocular drug delivery technology, Vitrasert®, in Europe and the world’s second, Retisert®, in the USA. Michael was the first European Marketing Director for Chiron Vision Europe. Additional experience includes setting up Alza International’s (drug delivery) European division, Pfizer Hospital Products (Howmedica, Orthopedics) in Europe and Asia and 3M Pharmaceuticals in the UK. He is Chairman of The Foundation Board for Lions Eye Institute for Transplant & Research. Michael was a member of the GrayBug scientific advisory board before his appointment as President & CEO in October 2013.
